|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities | ||
| Loss for the period | ||
| Adjustments to reconcile loss for the year to net cash used in operating activities: | ||
| Depreciation | ||
| Amortization | ||
| Impairment of property, plant and equipment | ||
| Write-down of excess inventories | ||
| Net finance expenses | ||
| Equity based share based payment transactions | ||
| Increase in research and development tax credit receivable | ||
| Research and development tax credit received, net of tax paid | ||
| Accrued preferred shares dividends | ||
| Changes to working capital: | ||
| Inventories | ||
| Trade and other receivables | ||
| Trade payables and other liabilities | ||
| Net Cash used in Operating Activities | ||
| Cash Flows from Investing Activities | ||
| Purchases of property, plant, equipment | ||
| Net Cash used in Investing Activities | ||
| Cash Flows from Financing Activities | ||
| Proceeds from issuance of share capital | ||
| Proceeds from issuance of convertible notes, net of issuance costs | ||
| Proceeds from instrument financing agreement | ||
| Proceeds from borrowings, net of issuance costs | ||
| Shares issued on the exercise of share options | ||
| Shares issued on employee stock purchase plan | ||
| Receipt of principal portion of lease receivable | ||
| Cash interest paid, net of interest received | ||
| Early extinguishment of debt | ||
| Cash issued for non-controlling interest | ||
| Repayment of lease liabilities | ||
| Repayments of instrument financing agreement | ||
| Repayments of borrowings | ||
| Net Cash generated from Financing Activities | ||
| Net (Decrease) / Increase in Cash and Cash Equivalents | ||
| Cash and Cash Equivalents at the end of the year | ||
| Movement in Cash and Cash Equivalents | ||
| Cash and cash equivalents at the beginning of the year | ||
| Exchange loss on cash and cash equivalents | ||
| Net Increase / (decrease) in cash and cash equivalents |
Loading...
